Pulmonx (LUNG) News Today $5.68 -0.01 (-0.18%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$5.68 0.00 (-0.09%) As of 01/31/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Glendon E. French III Sells 2,326 Shares of Pulmonx Co. (NASDAQ:LUNG) StockJanuary 22, 2025 | insidertrades.comPulmonx director French Glendon E. III sells shares worth $29,625January 22, 2025 | msn.comPulmonx Co. (NASDAQ:LUNG) Director Sells $15,188.78 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) Director Glendon E. French III sold 2,326 shares of the business's stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $6.53, for a total value of $15,188.78. Following the sale, the director now directly owns 1,069,648 shares of the company's stock, valued at approximately $6,984,801.44. This trade represents a 0.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.January 21, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Given Average Rating of "Moderate Buy" by BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the six research firms that are covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. TheJanuary 12, 2025 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six brokerages that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy reDecember 18, 2024 | marketbeat.comPulmonx (LUNG) was downgraded to a Hold Rating at CitiDecember 17, 2024 | markets.businessinsider.comPulmonx (LUNG) Gets a Buy from Lake StreetDecember 12, 2024 | markets.businessinsider.comCitigroup Downgrades Pulmonx (LUNG)December 12, 2024 | msn.comWhat People Living With COPD or Emphysema Need to Know About Available TreatmentsDecember 11, 2024 | yahoo.comPulmonx (LUNG) Gets a Hold from Wells FargoDecember 11, 2024 | markets.businessinsider.comPulmonx's (LUNG) "Neutral" Rating Reiterated at CitigroupCitigroup restated a "neutral" rating and set a $7.50 price target (down previously from $17.00) on shares of Pulmonx in a report on Wednesday.December 11, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 188,926 Shares of Pulmonx Co. (NASDAQ:LUNG)Jacobs Levy Equity Management Inc. reduced its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 38.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 301,361 shares of the company's stock after selling 188,926 sDecember 8, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Shares Purchased by Fmr LLCFmr LLC boosted its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 11.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 5,872,882 shares of the company's stock after acquiring an additional 591,859 shares during the period. Fmr LLC owned abDecember 8, 2024 | marketbeat.comPolar Asset Management Partners Inc. Makes New $893,000 Investment in Pulmonx Co. (NASDAQ:LUNG)Polar Asset Management Partners Inc. acquired a new stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 107,684 shares of the company's stock, valuedDecember 6, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Insider Sells $27,043.68 in StockDecember 5, 2024 | insidertrades.comAtom Investors LP Sells 92,305 Shares of Pulmonx Co. (NASDAQ:LUNG)Atom Investors LP cut its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 82.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,389 shares of the company's stock after selling 92,305 shares duriDecember 5, 2024 | marketbeat.comParkman Healthcare Partners LLC Makes New Investment in Pulmonx Co. (NASDAQ:LUNG)Parkman Healthcare Partners LLC acquired a new position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 206,444 shares of the company's stock, valued atDecember 4, 2024 | marketbeat.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) Director Sells 20,000 Shares of StockNovember 27, 2024 | insidertrades.comMillrace Asset Group Inc. Purchases Shares of 167,725 Pulmonx Co. (NASDAQ:LUNG)Millrace Asset Group Inc. acquired a new position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 167,725 shares of the company's stock, valued at approximately $1,390,000. Millrace ANovember 26, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of "Moderate Buy" by AnalystsPulmonx Co. (NASDAQ:LUNG - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have assigned a buy rNovember 23, 2024 | marketbeat.comPulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | globenewswire.comPulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersNovember 19, 2024 | finance.yahoo.comPulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 7, 2024 | markets.businessinsider.comPulmonx (LUNG) Gets a Buy from Stifel NicolausNovember 6, 2024 | markets.businessinsider.comPulmonx to Present at the Stifel 2024 Healthcare ConferenceNovember 5, 2024 | globenewswire.comPulmonx Corporation’s Financial Stability at Risk Amid Product and Market ChallengesNovember 3, 2024 | msn.comHere's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter ResultsNovember 2, 2024 | finance.yahoo.comPiper Sandler Remains a Buy on Pulmonx (LUNG)November 1, 2024 | markets.businessinsider.comPulmonx price target lowered to $10 from $12 at Piper SandlerNovember 1, 2024 | markets.businessinsider.comPulmonx Corp (LUNG) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...October 31, 2024 | finance.yahoo.comPulmonx Corporation Reports Solid Revenue Growth in Q3 2024October 31, 2024 | markets.businessinsider.comPulmonx (NASDAQ:LUNG) Stock Quotes, Forecast and News SummaryOctober 29, 2024 | benzinga.comEarnings Preview For PulmonxOctober 29, 2024 | benzinga.comPulmonx (LUNG) Set to Announce Quarterly Earnings on WednesdayPulmonx (NASDAQ:LUNG) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=465680)October 23, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Director Sells $130,400.00 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) Director Glendon E. French III sold 20,000 shares of the stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $6.52, for a total value of $130,400.00. Following the sale, the director now owns 1,091,974 shares in the company, valued at approximately $7,119,670.48. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.October 21, 2024 | marketbeat.comPulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024October 16, 2024 | globenewswire.comMillennium Management LLC Trims Holdings in Pulmonx Co. (NASDAQ:LUNG)Millennium Management LLC decreased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 31.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 448,623 shares of the company's stock after selling 201,6October 15, 2024 | marketbeat.comSquarepoint Ops LLC Purchases 104,432 Shares of Pulmonx Co. (NASDAQ:LUNG)Squarepoint Ops LLC lifted its stake in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 261.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 144,409 shares of the company's stock after purchasing an addiOctober 7, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from AnalystsPulmonx Co. (NASDAQ:LUNG - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The aOctober 4, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Position Lessened by Point72 Asset Management L.P.Point72 Asset Management L.P. reduced its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 91.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 240,949 shares of thOctober 4, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Director Sells $161,800.00 in StockSeptember 19, 2024 | insidertrades.comWells Fargo Reaffirms Their Hold Rating on Pulmonx (LUNG)September 10, 2024 | markets.businessinsider.comPulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024September 9, 2024 | globenewswire.comPulmonx Co. (NASDAQ:LUNG) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Pulmonx Co. (NASDAQ:LUNG - Get Free Report) have received an average rating of "Moderate Buy" from the six research firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and five have assigned a buy rating toSeptember 9, 2024 | marketbeat.comGeoffrey Beran Rose Sells 4,586 Shares of Pulmonx Co. (NASDAQ:LUNG) StockSeptember 6, 2024 | insidertrades.comPulmonx Co. (NASDAQ:LUNG) Insider Geoffrey Beran Rose Sells 4,586 SharesPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 4,586 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $6.70, for a total transaction of $30,726.20. Following the completion of the sale, the insider now owns 295,433 shares in the company, valued at $1,979,401.10. The transaction was disclosed in a legal filing with the SEC, which is available through this link.September 5, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest Down 8.2% in AugustPulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant decline in short interest in August. As of August 15th, there was short interest totalling 1,450,000 shares, a decline of 8.2% from the July 31st total of 1,580,000 shares. Currently, 4.1% of the company's stock are sold short. Based on an average daily volume of 369,800 shares, the days-to-cover ratio is currently 3.9 days.September 2, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Buys 69,595 Shares of Pulmonx Co. (NASDAQ:LUNG)BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 7.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,059,018 shares of the company'sSeptember 1, 2024 | marketbeat.comAeriseal’s Market Potential and Safety Profile: Justifying a Hold Rating for PulmonxAugust 31, 2024 | markets.businessinsider.comPulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceAugust 29, 2024 | finance.yahoo.com Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address LUNG Media Mentions By Week LUNG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUNG News Sentiment▼0.430.69▲Average Medical News Sentiment LUNG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUNG Articles This Week▼22▲LUNG Articles Average Week Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Paragon 28 News Today Establishment Labs News Today National Vision News Today Bioventus News Today CeriBell News Today AxoGen News Today Avanos Medical News Today Butterfly Network News Today Iradimed News Today SI-BONE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUNG) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
